MERRIMACK PHARMACEUTICALS INC Quarterly Common Stock, Shares Authorized from Q4 2011 to Q1 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Merrimack Pharmaceuticals Inc quarterly Common Stock, Shares Authorized history and growth rate from Q4 2011 to Q1 2024.
  • Merrimack Pharmaceuticals Inc Common Stock, Shares Authorized for the quarter ending March 31, 2024 was 30M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 30M 0 0% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 30M 0 0% Dec 31, 2023 10-Q 2024-05-15
Q3 2023 30M 0 0% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 30M 0 0% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 30M 0 0% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 30M 0 0% Dec 31, 2022 10-K 2024-03-07
Q3 2022 30M 0 0% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 30M 0 0% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 30M 0 0% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 30M 0 0% Dec 31, 2021 10-K 2023-03-09
Q3 2021 30M 0 0% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 30M 0 0% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 30M 0 0% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 30M 0 0% Dec 31, 2020 10-K 2022-03-09
Q3 2020 30M 0 0% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 30M 0 0% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 30M 0 0% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 30M 0 0% Dec 31, 2019 10-K 2021-03-10
Q3 2019 30M 0 0% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 30M 0 0% Jun 30, 2019 10-Q 2019-07-17
Q1 2019 30M +10M +50% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 30M +10M +50% Dec 31, 2018 10-K 2020-03-12
Q3 2018 30M +10M +50% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 30M -170M -85% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 20M -180M -90% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 20M 0 0% Dec 31, 2017 10-K 2019-03-06
Q3 2017 20M -180M -90% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 200M 0 0% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 200M 0 0% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 20M 0 0% Dec 31, 2016 10-K 2018-03-12
Q3 2016 200M 0 0% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 200M 0 0% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 200M 0 0% Mar 31, 2016 10-Q 2016-05-02
Q4 2015 20M -180M -90% Dec 31, 2015 8-K 2017-12-15
Q3 2015 200M 0 0% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 200M 0 0% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 200M 0 0% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 200M 0 0% Dec 31, 2014 10-K 2016-02-26
Q3 2014 200M 0 0% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 200M 0 0% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 200M 0 0% Mar 31, 2014 10-Q 2014-05-06
Q4 2013 200M 0 0% Dec 31, 2013 10-K 2015-02-27
Q3 2013 200M 0 0% Sep 30, 2013 10-Q 2013-11-08
Q2 2013 200M 0 0% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 200M 0 0% Mar 31, 2013 10-Q 2013-05-13
Q4 2012 200M +61.5M +44.4% Dec 31, 2012 10-K 2014-03-04
Q3 2012 200M Sep 30, 2012 10-Q 2012-11-14
Q2 2012 200M Jun 30, 2012 10-Q 2012-08-14
Q1 2012 200M Mar 31, 2012 10-K 2015-02-27
Q4 2011 139M Dec 31, 2011 10-K 2013-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.